Important Note: This peptide is strictly for laboratory and investigational use
Boskovic M, Vovk T, Koprivsek J, Plesnicar BK, Grabnar I
Several criticisms of the study of Schultz et al
Notably, lumateperone, an antagonist for D1, D2, D4, and serotonin receptor 2A and transporters (Kumar et al., 2018), improved depressive symptoms in bipolar depression patients in the first clinical trials (Calabrese et al., 2021), although it also showed potential inflammatory effects (El-Haroun et al., 2021)
The activity of dehydrogenases gets regulated through this process
Peptide Therapy: Short chains of amino acids that aid hormone regulation, tissue repair and immune function